Utilization of the residual plasma following preparation of factor VIII cryoprecipitate.
作者信息
Oberman H A, Penner J A
出版信息
JAMA. 1968 Sep 16;205(12):819-21.
PMID:5695503
Abstract
摘要
相似文献
1
Utilization of the residual plasma following preparation of factor VIII cryoprecipitate.
JAMA. 1968 Sep 16;205(12):819-21.
2
Treatment of congenital deficiencies of factor VIII and factor IX.
Thromb Diath Haemorrh Suppl. 1968;35:73-84.
3
Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.
Br Med J. 1967 Apr 8;2(5544):88-91. doi: 10.1136/bmj.2.5544.88.
4
Concentrated antihemophilic factor (AHF) from outdated blood.
Transfusion. 1967 May-Jun;7(3):168-73. doi: 10.1111/j.1537-2995.1967.tb05505.x.
5
Preparation of pooled cryoprecipitate for treatment of hemophilia A in a home care program.
Transfusion. 1984 Nov-Dec;24(6):520-3. doi: 10.1046/j.1537-2995.1984.24685066816.x.
6
[Transfusion therapy of hemophilia A and B].
Bibl Haematol. 1967;27:204-10.
7
Plasmapheresis of the patient as a method for achieving effective levels of plasma coagulation factors using fresh frozen plasma.
Transfusion. 1966 Jul-Aug;6(4):293-301. doi: 10.1111/j.1537-2995.1966.tb04742.x.
8
Acquired circulating anticoagulants in hemophilia A.
N Engl J Med. 1969 Oct 16;281(16):866-73. doi: 10.1056/NEJM196910162811603.
9
Fractions rich in factor VIII.
Bibl Haematol. 1968;29:1122-6. doi: 10.1159/000384749.
10
[Treatment of haemorrhages in a haemophiliac with factor-VIII inhibitor (author's transl)].
Dtsch Med Wochenschr. 1979 Feb 2;104(5):182-6. doi: 10.1055/s-0028-1103867.
Zotero 插件